Peptide and protein transdermal drug delivery
Peptides and proteins are gaining increasing importance as therapeutic agents. Oral delivery of these molecules is not feasible due to gastrointestinal degradation. Parenteral delivery leads to poor patient compliance especially because the short half-life of peptides necessitates repeated administr...
Gespeichert in:
| Veröffentlicht in: | Drug discovery today. Technologies 2012, Vol.9 (2), p.e147-e154 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e154 |
|---|---|
| container_issue | 2 |
| container_start_page | e147 |
| container_title | Drug discovery today. Technologies |
| container_volume | 9 |
| creator | Herwadkar, Anushree Banga, Ajay K. |
| description | Peptides and proteins are gaining increasing importance as therapeutic agents. Oral delivery of these molecules is not feasible due to gastrointestinal degradation. Parenteral delivery leads to poor patient compliance especially because the short half-life of peptides necessitates repeated administration. Passive transdermal delivery is not feasible but active transdermal delivery of peptides and proteins is a promising alternative route of administration which can bypass gastrointestinal degradation and offer patient compliance. This review discusses active transdermal technologies for delivery of peptides and proteins. |
| doi_str_mv | 10.1016/j.ddtec.2011.11.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1437119480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1740674911000278</els_id><sourcerecordid>1437119480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c274t-18cba45eb59325812fffd9b11ebc3df85125deea283527e6dba2fa95369ee45d3</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotlZ_gSCzdDNjbh7zWLiQ4gsKutB1yCR3JGVmWpOZQv-9qa3iSjhw7-Kc-_gIuQSaAYX8ZplZO6DJGAXIoigtjsgUCkHTvBDV8Z9-Qs5CWFLKRcXLUzJhguaCFXJK0ldcD85ionubrP1qQNcng9d9sOg73SbWjx-JxdZt0G_PyUmj24AXhzoj7w_3b_OndPHy-Dy_W6SGFWJIoTS1FhJrWXEmS2BN09iqBsDacNuUEpi0iJqVXLICc1tr1uhK8rxCFNLyGbnez40XfY4YBtW5YLBtdY-rMSgQvACoREmjle-txq9C8NiotXed9lsFVO04qaX65qR2nFRU5BRTV4cFY92h_c38gImG270B45sbh14F47A3aJ1HMyi7cv8u-ALD43my</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1437119480</pqid></control><display><type>article</type><title>Peptide and protein transdermal drug delivery</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><creator>Herwadkar, Anushree ; Banga, Ajay K.</creator><creatorcontrib>Herwadkar, Anushree ; Banga, Ajay K.</creatorcontrib><description>Peptides and proteins are gaining increasing importance as therapeutic agents. Oral delivery of these molecules is not feasible due to gastrointestinal degradation. Parenteral delivery leads to poor patient compliance especially because the short half-life of peptides necessitates repeated administration. Passive transdermal delivery is not feasible but active transdermal delivery of peptides and proteins is a promising alternative route of administration which can bypass gastrointestinal degradation and offer patient compliance. This review discusses active transdermal technologies for delivery of peptides and proteins.</description><identifier>ISSN: 1740-6749</identifier><identifier>EISSN: 1740-6749</identifier><identifier>DOI: 10.1016/j.ddtec.2011.11.007</identifier><identifier>PMID: 24064275</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Drug discovery today. Technologies, 2012, Vol.9 (2), p.e147-e154</ispartof><rights>2011 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c274t-18cba45eb59325812fffd9b11ebc3df85125deea283527e6dba2fa95369ee45d3</citedby><cites>FETCH-LOGICAL-c274t-18cba45eb59325812fffd9b11ebc3df85125deea283527e6dba2fa95369ee45d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ddtec.2011.11.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,4012,27910,27911,27912,45982</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24064275$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Herwadkar, Anushree</creatorcontrib><creatorcontrib>Banga, Ajay K.</creatorcontrib><title>Peptide and protein transdermal drug delivery</title><title>Drug discovery today. Technologies</title><addtitle>Drug Discov Today Technol</addtitle><description>Peptides and proteins are gaining increasing importance as therapeutic agents. Oral delivery of these molecules is not feasible due to gastrointestinal degradation. Parenteral delivery leads to poor patient compliance especially because the short half-life of peptides necessitates repeated administration. Passive transdermal delivery is not feasible but active transdermal delivery of peptides and proteins is a promising alternative route of administration which can bypass gastrointestinal degradation and offer patient compliance. This review discusses active transdermal technologies for delivery of peptides and proteins.</description><issn>1740-6749</issn><issn>1740-6749</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLAzEUhYMotlZ_gSCzdDNjbh7zWLiQ4gsKutB1yCR3JGVmWpOZQv-9qa3iSjhw7-Kc-_gIuQSaAYX8ZplZO6DJGAXIoigtjsgUCkHTvBDV8Z9-Qs5CWFLKRcXLUzJhguaCFXJK0ldcD85ionubrP1qQNcng9d9sOg73SbWjx-JxdZt0G_PyUmj24AXhzoj7w_3b_OndPHy-Dy_W6SGFWJIoTS1FhJrWXEmS2BN09iqBsDacNuUEpi0iJqVXLICc1tr1uhK8rxCFNLyGbnez40XfY4YBtW5YLBtdY-rMSgQvACoREmjle-txq9C8NiotXed9lsFVO04qaX65qR2nFRU5BRTV4cFY92h_c38gImG270B45sbh14F47A3aJ1HMyi7cv8u-ALD43my</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Herwadkar, Anushree</creator><creator>Banga, Ajay K.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2012</creationdate><title>Peptide and protein transdermal drug delivery</title><author>Herwadkar, Anushree ; Banga, Ajay K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c274t-18cba45eb59325812fffd9b11ebc3df85125deea283527e6dba2fa95369ee45d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herwadkar, Anushree</creatorcontrib><creatorcontrib>Banga, Ajay K.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today. Technologies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herwadkar, Anushree</au><au>Banga, Ajay K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peptide and protein transdermal drug delivery</atitle><jtitle>Drug discovery today. Technologies</jtitle><addtitle>Drug Discov Today Technol</addtitle><date>2012</date><risdate>2012</risdate><volume>9</volume><issue>2</issue><spage>e147</spage><epage>e154</epage><pages>e147-e154</pages><issn>1740-6749</issn><eissn>1740-6749</eissn><abstract>Peptides and proteins are gaining increasing importance as therapeutic agents. Oral delivery of these molecules is not feasible due to gastrointestinal degradation. Parenteral delivery leads to poor patient compliance especially because the short half-life of peptides necessitates repeated administration. Passive transdermal delivery is not feasible but active transdermal delivery of peptides and proteins is a promising alternative route of administration which can bypass gastrointestinal degradation and offer patient compliance. This review discusses active transdermal technologies for delivery of peptides and proteins.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24064275</pmid><doi>10.1016/j.ddtec.2011.11.007</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1740-6749 |
| ispartof | Drug discovery today. Technologies, 2012, Vol.9 (2), p.e147-e154 |
| issn | 1740-6749 1740-6749 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1437119480 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings |
| title | Peptide and protein transdermal drug delivery |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T12%3A59%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peptide%20and%20protein%20transdermal%20drug%20delivery&rft.jtitle=Drug%20discovery%20today.%20Technologies&rft.au=Herwadkar,%20Anushree&rft.date=2012&rft.volume=9&rft.issue=2&rft.spage=e147&rft.epage=e154&rft.pages=e147-e154&rft.issn=1740-6749&rft.eissn=1740-6749&rft_id=info:doi/10.1016/j.ddtec.2011.11.007&rft_dat=%3Cproquest_cross%3E1437119480%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1437119480&rft_id=info:pmid/24064275&rft_els_id=S1740674911000278&rfr_iscdi=true |